Zacks

Zacks Small Cap Research – AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of Hemopurifier – Go Health Pro

by
Zacks Small Cap Research – AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of Hemopurifier – Go Health Pro

By M. Marin NASDAQ:AEMD Aethlon Medical (NASDAQ:AEMD) announced that the first patient in its Australian safety, feasibility and dose-finding clinical trial has been treated with the Hemopurifier. The trial is designed for patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment. In other words, the trial is evaluating the Hemopurifier … Read more

Zacks Small Cap Research – PBSV Released Earnings and Declares Dividend – Go Health Pro

by

By Brad Sorensen, CFA OTC:PBSV READ THE FULL PBSV RESEARCH REPORT Pharma-Bio Serv (OTC:PBSV) announced results for the year ended October 31, 2024. The headline revenue and earnings releases were below expectations quarter, but management issued comments regarding future prospects that have us optimistic that the trend of decreasing revenue will soon be reversed. Management … Read more

Zacks Small Cap Research – SPGC: Sacks Parente Reports Preliminary Financial Results That Were Above Our Expectations – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:SPGC READ THE FULL SPGC RESEARCH REPORT On January 27, 2025, Sacks Parente Golf (NASDAQ:SPGC) provided preliminary financial results for the 4th quarter of 2024 and full year 2024. Revenue is expected to be between $1.1 million – $1.3 million in the 4th quarter of 2024, an increase of 882% … Read more

Zacks Small Cap Research – ENSC Continues to Announce Potential Life-Changing Results – Go Health Pro

by

By Brad Sorensen, CFA NASDAQ:ENSC READ THE FULL ENSC RESEARCH REPORT Ensysce Biosciences (NASDAQ:ENSC) is a clinical stage company that is developing treatments designed to have the same pain-relieving capabilities as opioids but come with the ability to inhibit abuse and overdoses. Opioid abuse is a national crisis, with the CDC estimating over 75,000 deaths … Read more

Zacks Small Cap Research – EZFL: Recent M&A Expected to Enhance Growth Prospects, as Footprint & Fleet Expand – Go Health Pro

by
Zacks Small Cap Research – EZFL: Recent M&A Expected to Enhance Growth Prospects, as Footprint & Fleet Expand – Go Health Pro

By M. Marin NASDAQ:EZFL Advancing strategy to be a leading on-demand mobile fueling company… EzFill Holdings (NASDAQ:EZFL) provides a mobile fuel delivery service that offers convenience to owners of commercial fleets and consumer vehicles. Its target market ranges from individual automobile owners to business fleets. The company brings refueling to the vehicles at their primary … Read more

x